• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 65-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
AEK-6991738-9/3/1 16-Sep-2004 65ACB99 3004410081 Speedex Sa Greece
 
AEK-6990004-7/6/4 29-Sep-2004 65ACL99 3004646335 Indoco Remedies Limited India
 
F23-0930552-2/1/1 13-Sep-2004 65JCS21 3004248544 CHANGZHOU MEDICAL RAW MATERIAL FACTORY China
 
AEK-6994282-5/1/1 15-Sep-2004 65JDA10 3004724229 Dhl Lebanon Lebanon
 
231-1741026-9/1/1 08-Sep-2004 65JIS21 1000654629 Pfizer Manufacturing Belgium NV Belgium
 
JN4-0027295-9/2/1/A 18-Sep-2004 65LBL11 3004511554 Christian Dior Cosmetic/Perfumes France
 
JN4-0027295-9/2/1/B 18-Sep-2004 65LBL11 3004511554 Christian Dior Cosmetic/Perfumes France
 
JN4-0027295-9/7/1/A 18-Sep-2004 65LBL11 1000233216 Kose Corporation Japan
 
442-7208861-6/1/8 20-Sep-2004 65LBL11 3004649131 Laboratorios Medicare S.L. Spain
 
442-7208861-6/1/9 20-Sep-2004 65LBL11 3004649131 Laboratorios Medicare S.L. Spain
 
JN4-0027295-9/1/1/B 18-Sep-2004 65LBL99 3004147022 Max Factor Ltd Japan
 
JN4-0027295-9/1/1/C 18-Sep-2004 65LBL99 3004147022 Max Factor Ltd Japan
 
JN4-0027295-9/7/1/B 18-Sep-2004 65LBL99 3004531822 Sanyan Taiwan
 
JN4-0027295-9/7/1/C 18-Sep-2004 65LBL99 1000233216 Kose Corporation Japan
 
XXX-0061630-1/1/1 18-Sep-2004 65PAA02 3004022528 NET FINANCE VI Costa Rica
 
112-4491146-7/2/2 14-Sep-2004 65QCK37 3004423487 Prollenium Medical Technologies Inc. Canada
 
336-2125808-9/2/1 08-Sep-2004 65QCY25 3002807919 Prime European Therapeuticals S.p.A., abbr Euticals S.p.A. Italy
 
336-2125808-9/1/1 08-Sep-2004 65QCY66 3002807919 Prime European Therapeuticals S.p.A., abbr Euticals S.p.A. Italy
 
AEK-6989199-8/2/1 16-Sep-2004 65QDB24 3004641951 Kaswar Hospital Pakistan
 
T94-0036371-7/37/1 13-Sep-2004 65SAJ99 3004626364 Www.Lacarretica.Com Costa Rica
 
112-4429248-8/4/1 15-Sep-2004 65VCA56 3004718471 Sanofi-Synthelabo Korea Korea, Republic Of (South)
 
-
-